BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 4, 2018
View Archived Issues
FDA accepts Selecta Biosciences' IND for SEL-403
Read More
Longevity Biotech awarded NIH contract to develop 5A apoA-I mimetic peptide for severe asthma
Read More
Patient enrollment ongoing in phase I study of cytomegalovirus vaccines mRNA-1647 and mRNA-1443
Read More
Sarepta Therapeutics begins enrollment in phase I study of SRP-5051
Read More
Simultaneous deletions of genes on two CDRs cooperate to induce B-cell abnormalities in mice
Read More
Sangamo, Pfizer to develop zinc finger protein gene therapy for ALS
Read More
Allergan exercises options for DARPin product candidates
Read More
FDA clears Palatin's IND for ulcerative colitis drug candidate
Read More
VistaGen Therapeutics' AV-101 awarded FDA fast track designation
Read More
Acacia Pharma announces FDA acceptance of NDA filing for Baremsis
Read More
HDAC11 found to be a therapeutic target for multiple myeloma
Read More
Expansion Therapeutics closes series A financing
Read More
Opthea commences phase Ib/IIa study of OPT-302 in DME
Read More
Asana BioSciences cleared to begin clinical testing of ASN-007
Read More
Paratek reviews progress in product pipeline
Read More
VenatoRx's VNRX-5133 given QIDP and fast track designations in U.S.
Read More
Jiangsu Hengrui Medicine patents ROM-K inhibitors
Read More
Rasna Therapeutics reports follow-up phase II data on actinomycin D in AML
Read More
Eli Lilly & Co. divulges new IDH1 mutant inhibitors
Read More
Bristol-Myers Squibb identifies EDL inhibitors
Read More
H1 receptor antagonists presented by Shenzhen Targetrx Biotechnology
Read More
Medshine Discovery divulges novel PKB inhibitors
Read More
Arvinas and Pfizer establish research collaboration and license agreement
Read More
FDA grants breakthrough therapy designation to Promacta for first-line use in severe aplastic anemia
Read More
EMA accepts CMA application for avacopan for ANCA-associated vasculitis
Read More
Phase Ib/II data on TAK-659 presented for relapsed/refractory AML
Read More
Five Prime submits IND for immuno-oncology therapy FPA-150
Read More